Mapping of Indonesians' Skin Type Based on Baumann Skin Type Indicator-Indonesia and Development of Artificial Intelligence Modelling

NCT05844904 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1950

Last updated 2023-09-28

No results posted yet for this study

Summary

The goal of this observational study is to learn about the skin type of Indonesians based on Baumann Skin Type Indicator Questionnaire in Indonesian language version, and to develop artificial intelligence modelling of BSTI-Ina. The main questions it aims to answer are:

1. What is the measurement of the validity and reliability of BSTI-Ina questionnaire year 2006 version which was adapted from BSTI questionnaire in English language year 2006 version as a specific measurement to identify skin type?
2. What is the measurement of the validity and reliability of BSTI-Ina questionnaire year 2022 version which was adapted from BSTI questionnaire in English language year 2022 version as a specific measurement to identify skin type?
3. What is the comparison of the validity and reliability between BSTI-Ina questionnaire year 2006 and year 2022 to determine Indonesian adult population's skin type?
4. How is the mapping of Indonesians' skin type based on BSTI-Ina?
5. What is the proportion of each skin type based on BSTI-Ina in Indonesian population?
6. What is the proportion of each skin type based on BSTI-Ina in Indonesian population sociodemographically?
7. How can Artificial Intelligence help categorize skin type based on BSTI-Ina automatically?

Participants are males and females between 18-59 year old. Participants will be asked to fill BSTI-Ina questionnaire. Participants then will be photographed in five different positions.

Conditions

  • Baumann Skin Type Indicator

Sponsors & Collaborators

  • Indonesian Society of Dermatology and Venereology

    collaborator UNKNOWN
  • College of Dermatologist and Venereologist

    collaborator UNKNOWN
  • Indonesia Medical Education and Research Institute

    collaborator OTHER
  • Dr.dr.Irma Bernadette, SpKK (K)

    lead OTHER

Principal Investigators

  • Irma Bernadette, MD · Faculty of Medicine, University of Indonesia

  • Hanny Nilasari, MD · Faculty of Medicine, University of Indonesia

  • Sandra Widaty, MD · Faculty of Medicine, University of Indonesia

  • Nelva K Jusuf, MD · Faculty of Medicine, University of North Sumatra

  • Puguh Riyanto, MD · Faculty of Medicine, Diponegoro University

  • Asnawi Madjid, MD · Faculty of Medicine, Hasanuddin University

  • Marlyn G Kapantow, MD · Faculty of Medicine, Sam Ratulangi University

  • I Gusti Ayu A Praharsini, MD · Faculty of Medicine, Udayana University

  • Reti Hindritiani, MD · Faculty of Medicine, Padjadjaran University

  • Diah M Indramaya, MD · Faculty of Medicine, Airlangga University

  • Yuli Kurniawati, MD · Faculty of Medicine, Sriwijaya University

  • Satya W Yenny, MD · Faculty of Medicine, Andalas University

  • Arie Kusumawardani, MD · Faculty of Medicine, Sebelas Maret University

  • Shinta Murlistyarini, MD · Faculty of Medicine, Brawijaya University

  • Flandiana Yogianti, MD · Faculty of Medicine, Gadjah Mada University

  • Aria Kekalih, MD · Faculty of Medicine, University of Indonesia

  • Prasandhya A Yusuf, PhD · Indonesia Medical Education and Research Institute, University of Indonesia

  • Eric D Tenda, MD · Indonesia Medical Education and Research Institute, University of Indonesia

  • Vanya V Valindria, PhD · Indonesia Medical Education and Research Institute, University of Indonesia

  • Sari Chairunnisa, MD · Paragon Technology & Innovation

  • Irwan Batubara, MD · Faculty of Medicine, University of Indonesia

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-08
Primary Completion
2023-11-01
Completion
2023-12-01

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05844904 on ClinicalTrials.gov